Cargando…

Loss of Par1b/MARK2 primes microglia during brain development and enhances their sensitivity to injury

BACKGROUND: Microglia, the resident immune cells of the brain, exhibit various morphologies that correlate with their functions under physiological and pathological conditions. In conditions such as aging and stress, microglia priming occurs, which leads to altered morphology and lower threshold for...

Descripción completa

Detalles Bibliográficos
Autores principales: DiBona, Victoria L., Zhu, Wenxin, Shah, Mihir K., Rafalia, Aditi, Ben Cheikh, Hajer, Crockett, David P., Zhang, Huaye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335724/
https://www.ncbi.nlm.nih.gov/pubmed/30654821
http://dx.doi.org/10.1186/s12974-018-1390-3
_version_ 1783387946607443968
author DiBona, Victoria L.
Zhu, Wenxin
Shah, Mihir K.
Rafalia, Aditi
Ben Cheikh, Hajer
Crockett, David P.
Zhang, Huaye
author_facet DiBona, Victoria L.
Zhu, Wenxin
Shah, Mihir K.
Rafalia, Aditi
Ben Cheikh, Hajer
Crockett, David P.
Zhang, Huaye
author_sort DiBona, Victoria L.
collection PubMed
description BACKGROUND: Microglia, the resident immune cells of the brain, exhibit various morphologies that correlate with their functions under physiological and pathological conditions. In conditions such as aging and stress, microglia priming occurs, which leads to altered morphology and lower threshold for activation upon further insult. However, the molecular mechanisms that lead to microglia priming are unclear. METHODS: To understand the role of Par1b/MARK2 in microglia, we first expressed shRNA targeting luciferase or Par1b/MARK2 in primary microglial cells and imaged the cells using fluorescent microscopy to analyze for morphological changes. A phagocytosis assay was then used to assess functional changes. We then moved in vivo and used a Par1b/MARK2 knockout mouse model to assess for changes in microglia density, morphology, and phagocytosis using immunohistochemistry, confocal imaging, and 3D image reconstruction. Next, we used two-photon in vivo imaging in live Par1b/MARK2 deficient mice to examine microglia dynamics. In addition, a controlled-cortical impact injury was performed on wild-type and Par1b/MARK2-deficient mice and microglial response was determined by confocal imaging. Finally, to help rule out non-cell autonomous effects, we analyzed apoptosis by confocal imaging, cytokine levels by multiplex ELISA, and blood-brain barrier permeability using Evans Blue assay. RESULTS: Here, we show that loss of the cell polarity protein Par1b/MARK2 facilitates the activation of primary microglia in culture. We next found that microglia in Par1b/MARK2 deficient mice show increased density and a hypertrophic morphology. These morphological changes are accompanied with alterations in microglia functional responses including increased phagocytosis of neuronal particles early in development and decreased surveillance of the brain parenchyma, all reminiscent of a primed phenotype. Consistent with this, we found that microglia in Par1b/MARK2 deficient mice have a significantly lower threshold for activation upon injury. CONCLUSIONS: Together, our studies show that loss of Par1b/MARK2 switches microglia from a surveillant to a primed state during development, resulting in an increased neuroinflammatory response to insults. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-018-1390-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6335724
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63357242019-01-23 Loss of Par1b/MARK2 primes microglia during brain development and enhances their sensitivity to injury DiBona, Victoria L. Zhu, Wenxin Shah, Mihir K. Rafalia, Aditi Ben Cheikh, Hajer Crockett, David P. Zhang, Huaye J Neuroinflammation Research BACKGROUND: Microglia, the resident immune cells of the brain, exhibit various morphologies that correlate with their functions under physiological and pathological conditions. In conditions such as aging and stress, microglia priming occurs, which leads to altered morphology and lower threshold for activation upon further insult. However, the molecular mechanisms that lead to microglia priming are unclear. METHODS: To understand the role of Par1b/MARK2 in microglia, we first expressed shRNA targeting luciferase or Par1b/MARK2 in primary microglial cells and imaged the cells using fluorescent microscopy to analyze for morphological changes. A phagocytosis assay was then used to assess functional changes. We then moved in vivo and used a Par1b/MARK2 knockout mouse model to assess for changes in microglia density, morphology, and phagocytosis using immunohistochemistry, confocal imaging, and 3D image reconstruction. Next, we used two-photon in vivo imaging in live Par1b/MARK2 deficient mice to examine microglia dynamics. In addition, a controlled-cortical impact injury was performed on wild-type and Par1b/MARK2-deficient mice and microglial response was determined by confocal imaging. Finally, to help rule out non-cell autonomous effects, we analyzed apoptosis by confocal imaging, cytokine levels by multiplex ELISA, and blood-brain barrier permeability using Evans Blue assay. RESULTS: Here, we show that loss of the cell polarity protein Par1b/MARK2 facilitates the activation of primary microglia in culture. We next found that microglia in Par1b/MARK2 deficient mice show increased density and a hypertrophic morphology. These morphological changes are accompanied with alterations in microglia functional responses including increased phagocytosis of neuronal particles early in development and decreased surveillance of the brain parenchyma, all reminiscent of a primed phenotype. Consistent with this, we found that microglia in Par1b/MARK2 deficient mice have a significantly lower threshold for activation upon injury. CONCLUSIONS: Together, our studies show that loss of Par1b/MARK2 switches microglia from a surveillant to a primed state during development, resulting in an increased neuroinflammatory response to insults. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-018-1390-3) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-17 /pmc/articles/PMC6335724/ /pubmed/30654821 http://dx.doi.org/10.1186/s12974-018-1390-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
DiBona, Victoria L.
Zhu, Wenxin
Shah, Mihir K.
Rafalia, Aditi
Ben Cheikh, Hajer
Crockett, David P.
Zhang, Huaye
Loss of Par1b/MARK2 primes microglia during brain development and enhances their sensitivity to injury
title Loss of Par1b/MARK2 primes microglia during brain development and enhances their sensitivity to injury
title_full Loss of Par1b/MARK2 primes microglia during brain development and enhances their sensitivity to injury
title_fullStr Loss of Par1b/MARK2 primes microglia during brain development and enhances their sensitivity to injury
title_full_unstemmed Loss of Par1b/MARK2 primes microglia during brain development and enhances their sensitivity to injury
title_short Loss of Par1b/MARK2 primes microglia during brain development and enhances their sensitivity to injury
title_sort loss of par1b/mark2 primes microglia during brain development and enhances their sensitivity to injury
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335724/
https://www.ncbi.nlm.nih.gov/pubmed/30654821
http://dx.doi.org/10.1186/s12974-018-1390-3
work_keys_str_mv AT dibonavictorial lossofpar1bmark2primesmicrogliaduringbraindevelopmentandenhancestheirsensitivitytoinjury
AT zhuwenxin lossofpar1bmark2primesmicrogliaduringbraindevelopmentandenhancestheirsensitivitytoinjury
AT shahmihirk lossofpar1bmark2primesmicrogliaduringbraindevelopmentandenhancestheirsensitivitytoinjury
AT rafaliaaditi lossofpar1bmark2primesmicrogliaduringbraindevelopmentandenhancestheirsensitivitytoinjury
AT bencheikhhajer lossofpar1bmark2primesmicrogliaduringbraindevelopmentandenhancestheirsensitivitytoinjury
AT crockettdavidp lossofpar1bmark2primesmicrogliaduringbraindevelopmentandenhancestheirsensitivitytoinjury
AT zhanghuaye lossofpar1bmark2primesmicrogliaduringbraindevelopmentandenhancestheirsensitivitytoinjury